ERG and prostate carcinoma: Kohvakka and colleagues further demonstrated that the ERG- and AR-regulated lncRNA EPCART (ERG-positive PC-associated androgen responsive transcript) is functionally relevant for prostate cancer, as knockout of EPCART reduces migration and proliferation of LNCaP cells.